Related Experiment Videos

[Experimental magnesium ammonium phosphate lithiasis induced by Ureaplasma in the rat]

Nephrologie
|January 1, 1984
PubMed

Insights

Ureaplasma urealyticum, a urease-producing bacteria, can cause struvite bladder stones in rats. Acetohydroxamic acid and doxycycline effectively prevented stone formation in this infection model.

Area of Science:

  • Urology
  • Microbiology
  • Nephrology

Background:

  • Struvite urinary stones are frequently linked to urease-producing bacteria, such as Proteus.
  • Ureaplasma urealyticum, a common inhabitant of the human genito-urinary tract, possesses urease activity.

Purpose of the Study:

  • To investigate the potential role of Ureaplasma urealyticum in the formation of infection-induced struvite bladder stones.
  • To evaluate the efficacy of acetohydroxamic acid and doxycycline in preventing stone formation.

Main Methods:

  • Utilized a rat model (Sprague-Dawley male rats) previously established by Friedlander and Braude.
  • Infected the renal medulla of rats with Ureaplasma urealyticum (serotypes 1, 2, 3, 7) and Mycoplasma hominis.
  • Monitored stone formation and bacterial viability over time.
  • Administered acetohydroxamic acid and doxycycline to assess their preventative effects.

Main Results:

  • Ureaplasma urealyticum infection led to struvite bladder stone formation in 60% of rats.
  • Mycoplasma hominis infection resulted in stone formation in only 10% of rats.
  • Pure struvite stones appeared within 4-5 days post-inoculation; U. urealyticum viability was typically limited to 6 days.
  • Acetohydroxamic acid and doxycycline successfully prevented struvite stone formation.

Conclusions:

  • Ureaplasma urealyticum is implicated in the pathogenesis of struvite bladder stones.
  • The urease activity of U. urealyticum plays a key role in stone formation.
  • Pharmacological interventions, including acetohydroxamic acid and doxycycline, can prevent infection-induced struvite stones.

Related Concept Videos